RT Journal Article
SR Electronic
T1 A Systematic Review and Meta-Analysis: Research Using the Autism Polygenic Score
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.08.24303918
DO 10.1101/2024.03.08.24303918
A1 de Wit, M.M.
A1 Morgan, M.J.
A1 Libedinsky, I.
A1 Austerberry, C.
A1 Begeer, S.
A1 Abdellaoui, A.
A1 Ronald, A.
A1 Polderman, T.J.C.
YR 2024
UL http://medrxiv.org/content/early/2024/03/09/2024.03.08.24303918.abstract
AB Objective Genetic factors play a substantial role in the etiology of autism and its co-occurrence with other conditions and traits. The autism polygenic score, derived from the latest autism case-control meta-genome-wide association studies, captures some of the accumulated influence of common genetic variants on autism. We reviewed and meta-analyzed published studies that assessed the relationship between this autism polygenic score and autism diagnosis, and autistic, behavioral and neurobiological traits.Method Systematically searching public databases, we identified 72 studies and > 750 outcome measures. Included studies received a quality assessment.Results The majority of included studies were rated as good quality. The autism polygenic score was most strongly associated with autism diagnosis (meta-analytic r = .162, 95% CI .066 – .258). The autism polygenic score was also significantly associated with autistic traits but to a lesser degree than for autism (meta-analytic r = .042 (95% CI .004 – .081). Associations with other outcomes were inconsistent and meta-analytic effect sizes were generally small (median r = .03).Conclusion We conclude that the current autism polygenic score is consistently associated with autism diagnostic status and autistic traits, but overlap between autism and other traits and conditions is not, from publications to date, explained significantly by the autism polygenic score. When compared to other mental conditions, autism is phenotypically and etiologically heterogeneous, which might drive the relatively modest associations observed with the autism polygenic score to date.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors SB, TP and MdW are supported by ZonMw grant number 60-63600-98-834.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data extracted for this study are available upon reasonable request to the authors.